2023 brings increased expectations from the FDA for patient-focused drug development (PFDD). Medical Affairs organizations need to develop new skills to put the patient voice at the center of drug, device, and diagnostic development and evaluation.
Based on discussions between 80 cross-industry Field Medical colleagues from small to large biopharmaceutical and medtech companies, this article highlights key actions for Medical Affairs teams to consider for implementation in their own organizations.
MAPS speaks with Eric Peacock, co-Founder and CEO of MyHealthTeam, about the alignment between social justice and business best-practices to promote health equity using patient communities.
This Altmetric White Paper explores how to measure the value of Medical Affairs publications beyond counting citations.
This article outlines the aspects of Medical Affairs strategy and launch excellence specific to supporting the development and launch of treatments targeting rare diseases, providing a roadmap for MA teams and organizations undertaking this planning.
MAPS speaks with Sameer Lal, SVP, Enterprise Medical Business Unit, Indegene about how to move from today’s largely siloed customer engagement framework to a truly cross-functional, omnichannel approach.
Today, HCPs are taking to the internet to release new research or create a digital research community in real-time. Through social media channels like Twitter, the new thought leaders or digital opinion leaders (DOLs) share research and reach a broader audience with digital influence and presence.
This webinar demonstrates how enhanced visualization solutions can be applied to scientific communications and Medical Affairs tools to enhance content clarity and increase HCP engagement.
This white paper by the MAPS Executive Consortium synthesizes the views of senior global Medical Affairs leaders to provide a unified vision for the future of Medical Affairs in society, industry, teams and as individuals.
This webinar tackles questions around how customer engagement is being approached as of today and helps redefine the industry thinking on this important topic for Medical Affairs.